Shi‐Bei Tan

机构：National University of Singapore · ORCID：0000-0001-6388-4390

发表论文 15 篇 · 总被引 155 次 · h-index 8

代表论文

• PRECISE CURATE.AI: A prospective feasibility trial to dynamically modulate personalized chemotherapy dose with artificial intelligence. (2022 · Journal of Clinical Oncology · 被引 28)
• Personalized dose selection platform for patients with solid tumors in the PRECISE CURATE.AI feasibility trial (2025 · npj Precision Oncology · 被引 24)
• CURATE.AI-assisted dose titration for anti-hypertensive personalized therapy: study protocol for a multi-arm, randomized, pilot feasibility trial using CURATE.AI (CURATE.AI ADAPT trial) (2023 · European Heart Journal - Digital Health · 被引 21)
• Discovery of Broad‐Spectrum Repurposed Drug Combinations Against Carbapenem‐Resistant Enterobacteriaceae (CRE) Through Artificial Intelligence (AI)‐Driven Platform (2024 · Advanced Therapeutics · 被引 16)
• IDentif.AI-Omicron: Harnessing an AI-Derived and Disease-Agnostic Platform to Pinpoint Combinatorial Therapies for Clinically Actionable Anti-SARS-CoV-2 Intervention (2022 · ACS Nano · 被引 16)
• Radiation therapy with phenotypic medicine: towards N-of-1 personalization (2024 · British Journal of Cancer · 被引 15)